BioHarvest Sciences to Present at 2026 BIO International Convention
BioHarvest Sciences Inc. announced it will present at the 2026 BIO International Convention in San Diego, California, from June 22-25. The company will showcase its proprietary Botanical Synthesis™ platform on June 24, aiming to engage with pharmaceutical and life science organizations. This presentation seeks to advance discussions with prospective partners for drug discovery, active pharmaceutical ingredients, and next-generation therapeutics, fostering long-term growth and shareholder value.
Key Highlights
- BioHarvest Sciences to present at the 2026 BIO International Convention in San Diego.
- Presentation scheduled for Wednesday, June 24, at 11:45 AM in Theater 3.
- Company will showcase its proprietary Botanical Synthesis™ platform technology.
- Aims to engage with pharmaceutical and life science organizations for strategic collaborations.
- Focus on drug discovery, active pharmaceutical ingredients, and next-generation therapeutics.
- Chairman and CEO Zaki Rakib will be available for additional meetings.
Price Impact
More from BHST
BioHarvest Sciences Q1 Revenue Up 8% to $8.5M; CDMO Revenue +135%
BioHarvest Sciences Q1 Net Loss $2.64M; Revenue $8.51M; Going Concern
BioHarvest Sciences Appoints Nedira Salzman-Frenkel as VP of Business Development